Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Sales | 0 | 7 | 9 | 0 | 0 |
| Gross Profit | 0 | 7 | -30 | 0 | 0 |
| Operating Expenses | 2,930 | 2,190 | 2,500 | 3,410 | 1,860 |
| Operating Income | -2,930 | -2,183 | -2,491 | -3,410 | -1,860 |
| Interest Expense | 0 | 0 | 7 | 6 | 10 |
| Other Income | 130 | 123 | 798 | 66 | 30 |
| Pre-tax Income | -2,800 | -2,060 | -1,700 | -3,350 | -1,840 |
| Net Income Continuous | -2,803 | -2,062 | -1,688 | -3,354 | -1,849 |
| Net Income | $-2,803 | $-2,062 | $-1,688 | $-3,354 | $-1,849 |
| EPS Basic Total Ops | -40.82 | -31.21 | -28.81 | -57.62 | -33.61 |
| EPS Basic Continuous Ops | -40.39 | -30.50 | -29.15 | -57.53 | -35.29 |
| EPS Diluted Total Ops | -40.82 | -31.21 | -28.81 | -57.62 | -33.61 |
| EPS Diluted Continuous Ops | -40.39 | -30.50 | -29.15 | -57.53 | -35.29 |
| EBITDA(a) | $-2,900 | $-2,153 | $-2,461 | $-3,140 | $-1,650 |